Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

431
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
431

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful minimal-invasive management of misplaced sacroiliac screw perforating the left external iliac vein: an interdisciplinary intervention by angiology and traumatology-a case report.

Journal of medical case reports·2026
Same author

Microchannel-Guided Revascularization of Tibial Chronic Total Occlusions Using a 0.009-Inch Tapered-Tip Guidewire.

The American journal of cardiology·2026
Same author

State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach.

Journal of cardiovascular development and disease·2026
Same author

Carotid artery stenting in asymptomatic disease: a new paradigm.

European heart journal·2026
Same author

One-month dual antiplatelet therapy after biodegradable-polymer everolimus-eluting stent implantation in diabetic patients at high bleeding risk.

European heart journal open·2026
Same author

Comparison of Sirolimus- vs Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Artery Disease: The SIRONA Randomized Noninferiority Trial.

Journal of the American College of Cardiology·2026

Related Experiment Video

Updated: Mar 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

Independent Modular Filter for Embolic Protection in Carotid Stenting.

Dierk Scheinert1, Bernhard Reimers1, Alberto Cremonesi1

  • 1From the Department of Interventional Angiology, Herzzentrum Leipzig GmbH and Park-Krankenhaus, Leipzig, Germany (D.S., A.S.); Department of Clinical and Invasive Cardiology, Humanitas Clinica and Research Center, Rozzano (Milan), Italy (B.R.); Department of Interventional Cardio-Angiology, Villa Maria Cecilia, Cotignola (RA), Italy (A.C.); Department Internal Medicine, Cardiology and Vascular Medicine, CardioVascular Center, Frankfurt, Germany (H.S.); Department of Radiology and Neuroradiology, Klinikum Dortmund, Dortmund, Germany (S.R.); Department of Cardiology, Hamburg University Cardiovascular Center, Hamburg, Germany (J.S.); Department of Cardiology, Klinikum Neuperlach, Munchen, Germany (H.G.M.); Department of Vascular Surgery, AZ Sint Blasius, Dendermonde, Belgium (M.B.); Department Angiology Internist, Universitats Herzzentrum, Bad Krozingen, Germany (T.Z.); Department of Cardiology, Mirano Hospital, Italy (A.P.); and Bnai Zion Medical Center, Technion-Israel Institute of Technology, Haifa, Israel (U.R.).

Circulation. Cardiovascular Interventions
|March 12, 2017
PubMed
Summary
This summary is machine-generated.

The Wirion Embolic Protection System demonstrated a significantly lower rate of death, stroke, and myocardial infarction in patients undergoing carotid artery stenting compared to historical data.

Keywords:
carotid arteryembolic protectionembolic strokemyocardial infarctionstenting

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

675
A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

753

Related Experiment Videos

Last Updated: Mar 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

675
A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

753

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Carotid artery stenting (CAS) is a procedure to open narrowed carotid arteries.
  • Thromboembolic events are a significant risk during CAS.
  • Embolic protection devices aim to reduce these complications.

Purpose of the Study:

  • To evaluate the safety and performance of the Wirion Embolic Protection System during CAS.
  • To assess the efficacy of the Wirion system in reducing adverse events in high-risk patients.

Main Methods:

  • Prospective, multicenter, nonrandomized, open-label, single-arm study (WISE study).
  • Interim analysis of the first 120 patients undergoing CAS with the Wirion system.
  • Primary endpoint: composite of death, stroke, and myocardial infarction at 30 days, compared to historical controls.

Main Results:

  • The primary endpoint occurred in 3.3% of patients with the Wirion system versus 6.3% in historical controls (P=0.0008).
  • Numerically lower rates of mortality (0% vs 1.7%), stroke (2.5% vs 4.6%), and myocardial infarction (0.8% vs 1.5%) were observed.
  • High rates of device, angiographic, procedural, and clinical success (99.2%, 99.1%, 98.3%, 96.6% respectively) were achieved.

Conclusions:

  • The Wirion Embolic Protection System is safe and effective for CAS in high surgical risk patients.
  • Use of this independent modular filter may reduce embolic complications during carotid stenting.